OQS
AMED

Occudo Quantitative Strategies’s Amedisys AMED Stock Holding History

Occudo Quantitative Strategies’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,070
Closed -$285K – 623
2025
Q1 		$285K Sell
3,070
-179
-6% -$16.5K 0.04% 485
2024
Q4 		$295K Buy
+3,249
New +$298K 0.05% 454
2023
Q1 		– Sell
-33,552
Closed -$2.8M – 888
2022
Q4 		$2.8M Buy
+33,552
New +$3.03M 0.33% 75
2021
Q4 		– Sell
-5,556
Closed -$828K – 1051
2021
Q3 		$828K Buy
+5,556
New +$1.15M 0.1% 364

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Occudo Quantitative Strategies's AMED Position: Q2 2025 in Review

Occudo Quantitative Strategies sold out of Amedisys (AMED) in Q2 2025, closing a stake of 3,070 shares — an estimated $285K sold.

Occudo Quantitative Strategies first reported a position in AMED in Q3 2021 and held it in 4 quarters. The position peaked at $2.8M in Q4 2022. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Occudo Quantitative Strategies reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 3,070 Amedisys shares in Q2 2025, an estimated $285K.
  • Occudo Quantitative Strategies first reported a position in Amedisys in Q3 2021 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Amedisys position peaked at $2.8M in Q4 2022.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.